title: Cognitive decline in Down syndrome.
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Margallo-Lana
authors.forename: Clive
authors.initials: C
authors.lastname: Ballard
authors.forename: Chris
authors.initials: C
authors.lastname: Morris
authors.forename: David
authors.initials: D
authors.lastname: Kay
authors.forename: Stephen
authors.initials: S
authors.lastname: Tyrer
authors.forename: Brian
authors.initials: B
authors.lastname: Moore
mesh_terms: D000328:Adult; D000367:Age Factors; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003072:Cognition Disorders / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D003704:Dementia / Q000150:complications / Q000175:diagnosis; D000077265:Donepezil; D004314:Down Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D007189:Indans; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D011569:Psychiatric Status Rating Scales
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil